# CYP2C9 Activity Evaluated With a Simple Finger Prick

> **NCT01026714** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Hospital, Geneva** · enrollment: 10 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** flurbiprofen
- **DRUG:** flurbiprofen, rifampicin
- **DRUG:** flurbiprofen + fluconazole

## Key facts

- **NCT ID:** NCT01026714
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2011-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01026714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01026714, "CYP2C9 Activity Evaluated With a Simple Finger Prick". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01026714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*